Jenny Brouns, RD, BSc

GIDietitian #IBS #IBD #GutHealth #MotilityDisorder UMC+Maastricht

[Jenny Brouns, RD, BSc @JennyBrouns]

Wat een fijne interactieve sfeer wist de PDSB neer te zetten tijdens de PDS-infodag 2023! Een erg leuke ervaring om deel te nemen in het gesprek tussen experts en de zaal.

[PDS Belangenorganisatie @PDSB]

Diëtist @JennyBrouns tijdens de PDS-infodag: het FODMAP-dieet is niet altijd nodig bij PDS. Laat niet te veel voedingsmiddelen weg. Het effect van voeding kan iedere dag anders zijn, afhankelijk van andere factoren. Groenten en fruit zijn altijd gezond voor je darmen.
#PDSdag

[John Damianos, M.D. @john_damianosMD]

Dysbiosis contributes to the development of diverticular disease. Targeting the microbiota may be able to improve outcomes.

#MedTwitter #GITwitter #microbiome

https://t.co/gI23Nftatc

[Jess Biesiekierski, PhD RNutr @jrbiesiekierski]

Highlights from our cross-sectional study exploring diet in functional dyspepsia:
- FODMAPs & fatty foods most common self reported dietary trigger of symptoms
- 88% have trialled diet restrictions
- need evidence-based diet management (#DDW2023 showed watch this space!)

[Jenny Brouns, RD, BSc @JennyBrouns]

@MCGdeGraaf @Nutrients_MDPI @IBS_Maastricht @MujagicZlatan @edithfeskens @PierikMarieke Van harte proficiat!👏🏼

[Marlijne de Graaf PhD @MCGdeGraaf]

Great start of the Christmas holidays: our paper on the association between #dietary intake of dicarbonyls and AGEs and #inflammation in #IBD and #IBS has been published in @Nutrients_MDPI!

https://t.co/j2DzlaIKk5

@IBS_Maastricht @MujagicZlatan @edithfeskens @PierikMarieke

[Jenny Brouns, RD, BSc @JennyBrouns]

@IBS_Maastricht @ERC_Research @WeertsZsaZsa @VorkLisa @MichelleBosman_ @KlaassenT Congratulations to all of you👏🏼!

[Daniel Keszthelyi MD PhD RFF @IBS_Maastricht]

So here are some pretty interesting results from a meta-analysis in @AGA_CGH on #placebo responses in #gastroparesis.

Overall placebo respons is 3⃣0⃣%
But adverse events occur even more frequently with placebo: 3⃣3⃣% of patients 🫢 i.e. nocebo effect

https://t.co/jwKxFuVQD1

[Maastricht UMC+ Gastroenterology & Hepatology @MUMC_GI]

Is surgery 🔪 effective in refractory cases of #gastroparesis?

Our group looked into this by systematic review now out in @SOARD_JOURNAL

▶️Sleeve gastrectomy and Roux-en-Y gastric bypass surgery may improve symptoms in selected cases

https://t.co/Ezzvl97vwk
#GITwitter

[Daniel Keszthelyi MD PhD RFF @IBS_Maastricht]

🆕 study presented as a poster at #ACG2022 shows that #gastroparesis is associated with more psychiatric disorders than functional dyspepsia

I must admit these figures are hard to digest. Almost half on SSRI and over 2/3 on benzodiazepines.
https://t.co/4pLSvSMHFi
#GItwitter

[Kevin Whelan @ProfWhelan]

People with #CrohnsDisease and #Colitis can have impaired food-related quality of life #FRQoL and those who do can eat less fibre and calcium.

We must support patients to overcome these problems
Full paper in @AJCNutrition👉🏽
https://t.co/d9DGJBZFmW

#UEGWeek #UEGWeek22 @my_ueg

[Daniel Keszthelyi MD PhD RFF @IBS_Maastricht]

🆕 updated @AmCollegeGastro guidelines on #gastroparesis now out in @AmJGastro

Although the algorithm might suggest otherwise, intrapyloric botulinum toxin is NOT recommended. Neither is the use of central neuromodulators or haloperidol.

#GITwitter
🔓https://t.co/rpQaL4CrRS

[UEGJ @UEGJournal]

📌 IBS with food-related symptoms

- current clinical approach
- future directions in management

Review article: https://t.co/mV3P9JQBzw

#GITwitter @my_ueg #MedEd @WileyHealth

[ignacio catalan @ign76]

💡Interested in novel strategies to treat IBD without immune suppression?

🍃 Happy to share our 2022 review on promising “Out of the box” therapies for Crohn’s! 👇🏻

🍎Diet, EEN, 🔵Tregs,🪲Phage therapy, 🪱helminths, 🫁Hyperbaric O2,⚡️Vagal N stimulation

https://t.co/KQdJxhjLXt

[Daniel Keszthelyi MD PhD RFF @IBS_Maastricht]

🚨@BritSocGastro guidelines on functional dyspepsia is out in @Gut_BMJ
🔓 https://t.co/sThaG1Aq6s

The pearls🦪:"The clinician should appear confident and, after the clinical assessment is complete, communicate a POSITIVE diagnosis of FD based on presence of typical symptoms."

[Daniel Keszthelyi MD PhD RFF @IBS_Maastricht]

"FD should be explained as a #DGBI that can be impacted by #diet, #stress, cognitive, behavioural, or emotional responses to symptoms & postinfection changes.

This aims to assist the patient in understanding and accepting the diagnosis & engaging with a shared management plan."

[Nick Trott @trott_nick]

Diet & Intestinal Bacterial Overgrowth: Is there evidence?

🔎 Studies - scarce & of low quality, limiting their clinical applicability.

⚖️ So far there is no specific diet for the treatment of #SIBO.

⬇️⬇️ https://t.co/Sdc6SLrczQ

[Daniel Keszthelyi MD PhD RFF @IBS_Maastricht]

🆕 European @my_ueg @esnm_eu guidelines for diarrhea #IBS
🗝️ takeaways:
⛔️ routine test for enteric 🦠 & #SIBO
⛔️ breath test for carbohydrate malabsorption
⛔️ #gluten free diet
⛔️ fecal 🦠 transplantation
✅ rifaximin
✅ probiotics
@UEGJournal #GITwitter
https://t.co/OgKmz7w2qN

[Rome PsychoGastroenterology @RomeGastroPsych]

How to reconcile the paradox of two conceptually opposite yet efficacious treatments for #IBS: the #FODMAP exclusion diet (promoting avoidance) and exposure-based CBT (reducing avoidance)?

Read the answer in @APandT from @JessBersa @labgas_kuleuven et al.
https://t.co/zfu9qjIKW1

[PDS Belangenorganisatie @PDSB]

In september start een nieuwe studie van Kenniscentrum #PDS @IBS_Maastricht van @MUMC_GI m.b.v. 2 apps. Hiermee gaan ze onderzoeken of ze een gepersonaliseerde leefstijlinterventie kunnen ontwikkelen voor PDS-patiënten. https://t.co/TwRHZdm6RN

[John Damianos, M.D. @john_damianosMD]

Excellent review on how specific dietary components impact the gut #microbiome.

#MedTwitter #medicine #diet #nutrition